fluorouracilleucovorinbevacizumaboxaliplatinirinotecanCRCcolorectal cancerSouthwest Oncology Group
…is cohort, high AXL predicted worse OS in patients treated with fluorouracil, leucovorin, and oxaliplatin/fluorouracil, leucovorin, and irin…
55articles mentioning drugs
136drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: bevacizumab ×
bevacizumab
This drug is selected. Its supporting articles are shown below.
Articles mentioning bevacizumab
55 articles · page 5 of 5NelmastobartcapecitabineoxaliplatinTrifluridine-tipiracilbevacizumabirinotecanmetastatic colorectal cancerSTCube PharmaceuticalmCRC
…mastobart, and no treatment-related deaths occurred.Conclusions Nelmastobart combined with capecitabine demonstrated a manageable safety pro…
AtezolizumabBevacizumabAtezo/BevHCCFudan Universityhepatocellular carcinomaImmune-checkpoint blockade therapiesZhongshan Hospital
… hepatocellular carcinoma (HCC) exhibiting varying responses to Atezolizumab plus Bevacizumab (Atezo/Bev), and profiled the tumor ecosystems…
IL-12IL-15IL-18pembrolizumabNivolumabfludarabineavelumabgemcitabinebevacizumabAtezolizumab+7 more
…d.aaf2341Leong JW, Chase JM, Romee R, et al. Preactivation with IL-12, IL-15, and IL-18 induces CD25 and a functional high-affinity I…
atezolizumabpemetrexedcarboplatinpaclitaxelbevacizumabABCPnon-small cell lung cancerNSCLC
…y and (2) 54 patients from the ATTLAS phase III trial comparing atezolizumab plus bevacizumab, paclitaxel, and carboplatin (ABCP) versus pem…
atezolizumabbevacizumabhepatocellular carcinomaimmunotherapy
…s of the tumor microenvironment (TME) and clinical outcome from atezolizumab plus bevacizumab (A+B).We therefore employed a supervised ML al…
INTESTIFIX 001-placeboINTESTIFIX 001sorafenibvancomycinatezolizumabvancomycin-placeboA/BbevacizumabmelanomaHCC
…in, A/B+INTESTIFIX 001 in comparison to vancomycin-placebo, A/B+INTESTIFIX 001-placebo and safety of the therapeutic combination in advanced HCC. INTE…